PortfoliosLab logo

AIM ImmunoTech Inc. (AIM)

Equity · Currency in USD · Last updated Aug 6, 2022

Company Info

ISINUS00901B1052
CUSIP00901B105
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.73
Year Range$0.67 - $2.12
EMA (50)$0.81
EMA (200)$1.14
Average Volume$168.62K
Market Capitalization$34.88M

AIMShare Price Chart


Chart placeholderClick Calculate to get results

AIMPerformance

The chart shows the growth of $10,000 invested in AIM ImmunoTech Inc. in Jan 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $23 for a total return of roughly -99.77%. All prices are adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%MarchAprilMayJuneJulyAugust
-11.54%
-8.32%
AIM (AIM ImmunoTech Inc.)
Benchmark (^GSPC)

AIMReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-7.03%8.19%
6M-7.03%-7.42%
YTD-21.17%-13.03%
1Y-64.28%-5.85%
5Y-47.18%10.86%
10Y-42.47%11.53%

AIMMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-8.70%-15.48%49.30%-0.94%-13.33%-14.29%-6.41%-0.66%
202113.41%11.33%0.44%-4.85%-4.63%4.37%-2.79%-1.44%-1.94%-11.39%-17.88%-37.41%
202083.62%105.23%24.88%-18.75%34.62%-11.43%17.74%-22.95%-4.44%-3.72%-11.11%-2.72%
201926.02%-21.09%-11.11%28.13%-49.27%-4.06%-46.47%-23.40%-57.67%-34.38%-20.02%36.03%
201845.92%-0.97%-21.00%-20.23%0.57%0.98%-9.37%-5.17%-16.36%0.48%-22.11%0.56%
2017-0.62%-29.26%12.41%22.91%-11.96%-15.24%-15.20%-14.39%-11.16%-3.88%3.23%8.13%
201611.80%55.56%-4.93%2.18%-12.87%-2.78%13.28%-6.77%-13.70%-22.22%-16.33%-15.88%
2015-12.04%10.50%-6.17%15.22%-13.97%-9.51%-4.65%-9.23%-3.67%-26.10%-3.97%-33.47%
201464.15%-8.51%0.50%-17.50%0.52%-6.54%-9.68%-2.50%17.55%-9.63%-10.34%-3.85%
201312.04%-21.71%-13.64%13.16%2.14%1.37%3.32%0.43%1.77%-5.87%-6.46%28.02%
2012125.53%-30.23%27.04%-19.23%-14.29%2.96%25.90%81.74%25.77%5.62%-8.88%-67.43%
2011-0.71%-8.16%2.22%8.70%-6.00%-16.17%-8.63%-17.36%4.20%-9.68%-29.71%-0.86%
201010.00%3.05%8.81%3.38%-14.12%-28.69%12.06%-5.05%12.84%-8.00%-5.29%0.69%

AIMSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current AIM ImmunoTech Inc. Sharpe ratio is -0.91. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00MarchAprilMayJuneJulyAugust
-0.91
-0.31
AIM (AIM ImmunoTech Inc.)
Benchmark (^GSPC)

AIMDividend History


AIM ImmunoTech Inc. doesn't pay dividends

AIMDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-99.86%
-13.58%
AIM (AIM ImmunoTech Inc.)
Benchmark (^GSPC)

AIMWorst Drawdowns

The table below shows the maximum drawdowns of the AIM ImmunoTech Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the AIM ImmunoTech Inc. is 99.93%, recorded on Nov 26, 2019. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.93%Sep 24, 20121806Nov 26, 2019
-78.3%Mar 12, 2010433Nov 25, 2011195Sep 5, 2012628
-14.67%Jan 15, 201011Feb 1, 201026Mar 10, 201037
-13.31%Sep 11, 20125Sep 17, 20123Sep 20, 20128
-9.42%Sep 6, 20121Sep 6, 20121Sep 7, 20122
-6.15%Jan 7, 20101Jan 7, 20104Jan 13, 20105
-5%Jan 5, 20101Jan 5, 20101Jan 6, 20102

AIMVolatility Chart

Current AIM ImmunoTech Inc. volatility is 49.66%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%MarchAprilMayJuneJulyAugust
49.66%
19.67%
AIM (AIM ImmunoTech Inc.)
Benchmark (^GSPC)